Final FDA approval of vagus nerve stimulation a treatment for chronic or recurrent treatment-resistant depression and released in May. Psychiatrist then officially be able to this extraordinary, life changing therapy for patients require.
On April 7, 2005 announced the manufacturer of the vagus nerve stimulator (Cyberonics, Inc.) which had been notified by the SU Food and Drug Administration (FDA) that one of the few conditions for final FDAApproval are met. Cyberonics also announced that they are very confident that the remaining two conditions are met expeditously and final approval by the FDA was granted in May.
Robert P. ("Skip") Cummins, Cyberonics' President and Chief Executive Officer, commented: "This important step towards compliance with Cyberonics mission to constantly improve" the lives of people touched by refractory epilepsy and treatmentDepression (TRD) would not have been possible without the team with the regulatory, diligent, interactive, timely and cooperative efforts of all staff Cyberonics Dallas District Office under the direction of Michael Chappell, District Director, and. Cyberonics and CDRH continue to make good progress towards our goal of satisfying the remaining conditions of TRD final approval. "
The official launch of the vagus nerve stimulation treatment for depression rather thanAmerican Psychiatric Association Annual Meeting of the World Congress Center in Atlanta, May 21 and May 25 The meeting will be attended by more than 20,000 psychiatrists.
Major depression is a common and serious diseases in the United States, affecting nearly 19 million Americans each year. Depression is the second leading cause of disability in the general population and the leading cause of disability for American women. About20 percent of Americans are depressed, or about four million people who suffer from chronic or recurrent treatment-resistant depression, did not respond to several antidepressant treatments. If approved, VNS Therapy System is the depression, the first implantable device-based treatment of depression and the first treatment developed, studied and labeled specifically for patients resistant to treatment.
Vagus nerveStimulation depression, the traditional treatment for chronic or resistant to treatment. About four million Americans suffer from chronic depression. The final approval by the FDA is the largest discoveries in the history of medical device to be considered.
To learn more about [http://www.VagusNerveStimulator.com]. There is a free electronic newsletter for up-to-date to keep.
medical for youe life medical
This entry was posted on Sunday, October 3rd, 2010 at 12:06 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.View the original article here
This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.
No comments:
Post a Comment